Turkova, Anna;
Waalewijn, Hylke;
Chan, Man K;
Bollen, Pauline DJ;
Bwakura-Dangarembizi, Mutsa F;
Kekitiinwa, Adeodata R;
Cotton, Mark F;
... Zuidewind, Peter; + view all
(2022)
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial.
The Lancet HIV
10.1016/s2352-3018(22)00160-6.
(In press).